知镜 Cognispect · 医学文献与研究工作台

PRP-activating hyaluronic acid hydrogels for immune-modulatory osteoarthritis repair

Hu Y, Shan W, Peng X, et al.
Bioact Mater · 2026-09-08 · PMID 42741686

文献摘要

Osteoarthritis (OA) is a prevalent whole-joint disease that requires effective disease-modifying therapies. Intra-articular platelet-rich plasma (PRP) injections offer a minimally invasive treatment option, but face two coupled challenges: premature ex vivo activation causes rapid growth-factor release before injection, and the inflamed, protease-rich synovial microenvironment accelerates their subsequent degradation. To address these barriers, we report an injectable dual-component hyaluronic acid (HA) hydrogel depot (PRP@Gel) that combines dynamic covalent HA-based delivery with a calcium-containing matrix designed to facilitate PRP activation and sustained immunomodulation. Distinct from conventional HA/PRP hydrogels that mainly improve local retention or deliver pre-activated PRP, PRP@Gel uses a calcium-integrated AHA-Ca backbone to support gradual post-injection PRP activation within the joint cavity, thereby limiting burst release of platelet-derived factors. Sustained calcitriol release concurrently promoted a tolerogenic DC phenotype in vitro and was associated with a shift from Th17-related responses toward Treg-related features. This immune modulation was associated with reduced MMP3 and CTSK expression, which may establish a less proteolytic microenvironment for PRP-derived factors. In a rat OA model, PRP@Gel treatment improved gait symmetry and cartilage integrity. Together, these findings support an integrated strategy that coordinates PRP activation with immune modulation to sustain regenerative signaling in OA joints.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。